Skip to main content
Erschienen in: European Journal of Nutrition 1/2021

30.03.2020 | Original Contribution

Dairy product intake modifies gut microbiota composition among hyperinsulinemic individuals

verfasst von: Leila Khorraminezhad, Mickael Leclercq, Sarah O’Connor, Pierre Julien, S. John Weisnagel, Claudia Gagnon, Arnaud Droit, Iwona Rudkowska

Erschienen in: European Journal of Nutrition | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purposes

The objectives of this study were to investigate differences in gut microbiota (GM) composition after high dairy intake (HD) compared to adequate dairy intake (AD) and to correlate GM composition variations with the change in glycemic parameters in hyperinsulinemic subjects.

Methods

In this crossover study, 10 hyperinsulinemic adults were randomized to HD (≥ 4 servings/day) or AD (≤ 2 servings/day) for 6 weeks, separated by a 6-week washout period. Fasting insulin and glucose levels were measured after each intervention. Insulin resistance was calculated with the homeostasis model assessment of insulin resistance (HOMA-IR). GM was determined with 16S rRNA-based high-throughput sequencing at the end of each intervention. Paired t test, correlations and machine learning analyses were performed.

Results

Endpoint glycemic parameters were not different between HD and AD intake. After HD compared with AD intake, there was a decrease in the abundance of bacteria in Roseburia and Verrucomicrobia (p = 0.04 and p = 0.02, respectively) and a trend for an increase abundance in Faecalibacteria and Flavonifractor (p = 0.05 and p = 0.06, respectively). The changes in abundance of Coriobacteriia, Erysipelotrichia, and Flavonifractor were negatively correlated with the change in HOMA-IR between the AD and HD phases. Furthermore, a predictive GM signature, including Anaerotruncus, Flavonifractor, Ruminococcaceae, and Subdoligranulum, was related to HOMA-IR.

Conclusion

Overall, these results suggest that HD modifies the abundance of specific butyrate-producing bacteria in Firmicutes and of bacteria in Verrucomicrobia in hyperinsulinemic individuals. In addition, the butyrate producing bacteria in Firmicutes phylum correlate negatively with insulin resistance.
Literatur
1.
Zurück zum Zitat Sender R, Fuchs S, Milo R (2016) Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 14:e1002533CrossRef Sender R, Fuchs S, Milo R (2016) Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 14:e1002533CrossRef
2.
Zurück zum Zitat Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy DN (2015) Role of the normal gut microbiota. World J Gastroenterol 21:8787CrossRef Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy DN (2015) Role of the normal gut microbiota. World J Gastroenterol 21:8787CrossRef
3.
Zurück zum Zitat Rajoka MSR, Shi J, Mehwish HM, Zhu J, Li Q, Shao D, Huang Q, Yang H (2017) Interaction between diet composition and gut microbiota and its impact on gastrointestinal tract health. Food Sci Hum Wellness 6:121–130CrossRef Rajoka MSR, Shi J, Mehwish HM, Zhu J, Li Q, Shao D, Huang Q, Yang H (2017) Interaction between diet composition and gut microbiota and its impact on gastrointestinal tract health. Food Sci Hum Wellness 6:121–130CrossRef
4.
Zurück zum Zitat Liang D, Leung RKK, Guan W, Au WW (2018) Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities. Gut pathog 10:3CrossRef Liang D, Leung RKK, Guan W, Au WW (2018) Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities. Gut pathog 10:3CrossRef
5.
Zurück zum Zitat Bo T, Shao S, Wu D, Niu S, Zhao J, Gao L (2017) Relative variations of gut microbiota in disordered cholesterol metabolism caused by high-cholesterol diet and host genetics. Microbiol Open 6:e00491CrossRef Bo T, Shao S, Wu D, Niu S, Zhao J, Gao L (2017) Relative variations of gut microbiota in disordered cholesterol metabolism caused by high-cholesterol diet and host genetics. Microbiol Open 6:e00491CrossRef
6.
Zurück zum Zitat Valle Gottlieb MG, Closs VE, Junges VM, Schwanke CHA (2018) Impact of human aging and modern lifestyle on gut microbiota. Crit Rev Food Sci Nutr 58:1557–1564CrossRef Valle Gottlieb MG, Closs VE, Junges VM, Schwanke CHA (2018) Impact of human aging and modern lifestyle on gut microbiota. Crit Rev Food Sci Nutr 58:1557–1564CrossRef
7.
Zurück zum Zitat Navab-Moghadam F, Sedighi M, Khamseh ME, Alaei-Shahmiri F, Talebi M, Razavi S, Amirmozafari N (2017) The association of type II diabetes with gut microbiota composition. Microbial Pathog 110:630–636CrossRef Navab-Moghadam F, Sedighi M, Khamseh ME, Alaei-Shahmiri F, Talebi M, Razavi S, Amirmozafari N (2017) The association of type II diabetes with gut microbiota composition. Microbial Pathog 110:630–636CrossRef
8.
Zurück zum Zitat Azcarate-Peril MA, Ritter AJ, Savaiano D, Monteagudo-Mera A, Anderson C, Magness ST, Klaenhammer TR (2017) Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. Proc Natl Acad Sci 114:E367–E375CrossRef Azcarate-Peril MA, Ritter AJ, Savaiano D, Monteagudo-Mera A, Anderson C, Magness ST, Klaenhammer TR (2017) Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. Proc Natl Acad Sci 114:E367–E375CrossRef
9.
Zurück zum Zitat Ferrocino I, Ponzo V, Gambino R, Zarovska A, Leone F, Monzeglio C, Goitre I, Rosato R, Romano A, Grassi G (2018) Changes in the gut microbiota composition during pregnancy in patients with gestational diabetes mellitus (GDM). Sci Rep 8:12216CrossRef Ferrocino I, Ponzo V, Gambino R, Zarovska A, Leone F, Monzeglio C, Goitre I, Rosato R, Romano A, Grassi G (2018) Changes in the gut microbiota composition during pregnancy in patients with gestational diabetes mellitus (GDM). Sci Rep 8:12216CrossRef
10.
Zurück zum Zitat Liu H, Zhang H, Wang X, Yu X, Hu C, Zhang X (2018) The family Coriobacteriaceae is a potential contributor to the beneficial effects of Roux-en-Y gastric bypass on type 2 diabetes. Surg Obes Relat Dis 14:584–593CrossRef Liu H, Zhang H, Wang X, Yu X, Hu C, Zhang X (2018) The family Coriobacteriaceae is a potential contributor to the beneficial effects of Roux-en-Y gastric bypass on type 2 diabetes. Surg Obes Relat Dis 14:584–593CrossRef
11.
Zurück zum Zitat Wang Y, Luo X, Mao X, Tao Y, Ran X, Zhao H, Xiong J, Li L (2017) Gut microbiome analysis of type 2 diabetic patients from the Chinese minority ethnic groups the Uygurs and Kazaks. PLoS ONE 12:e0172774CrossRef Wang Y, Luo X, Mao X, Tao Y, Ran X, Zhao H, Xiong J, Li L (2017) Gut microbiome analysis of type 2 diabetic patients from the Chinese minority ethnic groups the Uygurs and Kazaks. PLoS ONE 12:e0172774CrossRef
12.
Zurück zum Zitat Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55CrossRef Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55CrossRef
13.
Zurück zum Zitat Aydin Ö, Nieuwdorp M, Gerdes V (2018) The gut microbiome as a target for the treatment of type 2 diabetes. Curr Diabetes Rep 18:55CrossRef Aydin Ö, Nieuwdorp M, Gerdes V (2018) The gut microbiome as a target for the treatment of type 2 diabetes. Curr Diabetes Rep 18:55CrossRef
14.
Zurück zum Zitat Gao D, Ning N, Wang C, Wang Y, Li Q, Meng Z, Liu Y, Li Q (2013) Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS ONE 8:e73965CrossRef Gao D, Ning N, Wang C, Wang Y, Li Q, Meng Z, Liu Y, Li Q (2013) Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS ONE 8:e73965CrossRef
15.
Zurück zum Zitat Aune D, Norat T, Romundstad P, Vatten LJ (2013) Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr 98:1066–1083CrossRef Aune D, Norat T, Romundstad P, Vatten LJ (2013) Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr 98:1066–1083CrossRef
16.
Zurück zum Zitat Smith-Brown P, Morrison M, Krause L, Davies P (2016) Dairy and plant based food intakes are associated with altered faecal microbiota in 2 to 3 year old Australian children. Sci Rep 6:32385CrossRef Smith-Brown P, Morrison M, Krause L, Davies P (2016) Dairy and plant based food intakes are associated with altered faecal microbiota in 2 to 3 year old Australian children. Sci Rep 6:32385CrossRef
17.
Zurück zum Zitat Suzuki Y, Ikeda K, Sakuma K, Kawai S, Sawaki K, Asahara T, Takahashi T, Tsuji H, Nomoto K, Nagpal R (2017) Association between yogurt consumption and intestinal microbiota in healthy young adults differs by host gender. Front Microbiol 8:847CrossRef Suzuki Y, Ikeda K, Sakuma K, Kawai S, Sawaki K, Asahara T, Takahashi T, Tsuji H, Nomoto K, Nagpal R (2017) Association between yogurt consumption and intestinal microbiota in healthy young adults differs by host gender. Front Microbiol 8:847CrossRef
18.
Zurück zum Zitat Li X, Yin J, Zhu Y, Wang X, Hu X, Bao W, Huang Y, Chen L, Chen S, Yang W (2018) Effects of whole milk supplementation on gut microbiota and cardiometabolic biomarkers in subjects with and without lactose malabsorption. Nutrients 10:1403CrossRef Li X, Yin J, Zhu Y, Wang X, Hu X, Bao W, Huang Y, Chen L, Chen S, Yang W (2018) Effects of whole milk supplementation on gut microbiota and cardiometabolic biomarkers in subjects with and without lactose malabsorption. Nutrients 10:1403CrossRef
19.
Zurück zum Zitat Chen EA et al (2018) Dairy intake and mucosa-associated gut microbiome in healthy individuals: Presidential Poster Award:235. Am J Gastroenterol 113:S37 Chen EA et al (2018) Dairy intake and mucosa-associated gut microbiome in healthy individuals: Presidential Poster Award:235. Am J Gastroenterol 113:S37
20.
Zurück zum Zitat O'Connor S, Weisnagel SJ, Gagnon C, Rudkowska I (2019) Impact of a high intake of dairy product on insulin sensitivity in hyperinsulinemic adults: a cross-over randomized controlled trial. Curr Dev Nutr 3:nzz083CrossRef O'Connor S, Weisnagel SJ, Gagnon C, Rudkowska I (2019) Impact of a high intake of dairy product on insulin sensitivity in hyperinsulinemic adults: a cross-over randomized controlled trial. Curr Dev Nutr 3:nzz083CrossRef
21.
Zurück zum Zitat Passey RB, Gillum RL, Fuller JB, Urry FM, Giles ML (1977) Evaluation and comparison of 10 glucose methods and the reference method recommended in the proposed product class standard (1974). Clin Chem 23:131–139CrossRef Passey RB, Gillum RL, Fuller JB, Urry FM, Giles ML (1977) Evaluation and comparison of 10 glucose methods and the reference method recommended in the proposed product class standard (1974). Clin Chem 23:131–139CrossRef
22.
Zurück zum Zitat Kirk RE, Othmer Donald F, Standen A, Scott JD (1947) Encyclopedia of chemical technology. The Interscience Encyclopedia, Inc., New York Kirk RE, Othmer Donald F, Standen A, Scott JD (1947) Encyclopedia of chemical technology. The Interscience Encyclopedia, Inc., New York
23.
Zurück zum Zitat Dhariwal A, Chong J, Habib S, King IL, Agellon LB, Xia J (2017) Microbiome analyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res 45:W180–W188CrossRef Dhariwal A, Chong J, Habib S, King IL, Agellon LB, Xia J (2017) Microbiome analyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res 45:W180–W188CrossRef
24.
Zurück zum Zitat De Candia P, Spinetti G, Specchia C, Sangalli E, La Sala L, Uccellatore A, Lupini S, Genovese S, Matarese G, Ceriello A (2017) A unique plasma microRNA profile defines type 2 diabetes progression. PLoS ONE 12:e0188980CrossRef De Candia P, Spinetti G, Specchia C, Sangalli E, La Sala L, Uccellatore A, Lupini S, Genovese S, Matarese G, Ceriello A (2017) A unique plasma microRNA profile defines type 2 diabetes progression. PLoS ONE 12:e0188980CrossRef
25.
Zurück zum Zitat Alexander WM, Ficarro SB, Adelmant G, Marto JA (2017) multiplierz v2. 0: A Python-based ecosystem for shared access and analysis of native mass spectrometry data. Proteomics 17:1700091CrossRef Alexander WM, Ficarro SB, Adelmant G, Marto JA (2017) multiplierz v2. 0: A Python-based ecosystem for shared access and analysis of native mass spectrometry data. Proteomics 17:1700091CrossRef
26.
Zurück zum Zitat Healey GR, Murphy R, Brough L, Butts CA, Coad J (2017) Interindividual variability in gut microbiota and host response to dietary interventions. Nutr Rev 75:1059–1080CrossRef Healey GR, Murphy R, Brough L, Butts CA, Coad J (2017) Interindividual variability in gut microbiota and host response to dietary interventions. Nutr Rev 75:1059–1080CrossRef
27.
Zurück zum Zitat Fujio-Vejar S, Vasquez Y, Morales P, Magne F, Vera-Wolf P, Ugalde JA, Navarrete P, Gotteland M (2017) The gut microbiota of healthy chilean subjects reveals a high abundance of the phylum verrucomicrobia. Front Microbiol 8:1221CrossRef Fujio-Vejar S, Vasquez Y, Morales P, Magne F, Vera-Wolf P, Ugalde JA, Navarrete P, Gotteland M (2017) The gut microbiota of healthy chilean subjects reveals a high abundance of the phylum verrucomicrobia. Front Microbiol 8:1221CrossRef
28.
Zurück zum Zitat Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L (2013) Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE 8:e71108CrossRef Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L (2013) Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE 8:e71108CrossRef
29.
Zurück zum Zitat Chen E, Ajami N, Chen L, Plew S, White D, Wang Z, El-Serag H, Petrosino J, Jiao L (2018) Dairy intake and mucosa-associated gut microbiome in healthy individuals: Presidential Poster Award. Am J Gastroenterol 113:S137CrossRef Chen E, Ajami N, Chen L, Plew S, White D, Wang Z, El-Serag H, Petrosino J, Jiao L (2018) Dairy intake and mucosa-associated gut microbiome in healthy individuals: Presidential Poster Award. Am J Gastroenterol 113:S137CrossRef
30.
Zurück zum Zitat Burton KJ, Rosikiewicz M, Pimentel G, Bütikofer U, Von Ah U, Voirol M-J, Croxatto A, Aeby S, Drai J, McTernan PG (2017) Probiotic yogurt and acidified milk similarly reduce postprandial inflammation and both alter the gut microbiota of healthy, young men. Br J Nutr 117:1312–1322CrossRef Burton KJ, Rosikiewicz M, Pimentel G, Bütikofer U, Von Ah U, Voirol M-J, Croxatto A, Aeby S, Drai J, McTernan PG (2017) Probiotic yogurt and acidified milk similarly reduce postprandial inflammation and both alter the gut microbiota of healthy, young men. Br J Nutr 117:1312–1322CrossRef
31.
Zurück zum Zitat Saeb AT, Al-Rubeaan KA, Aldosary K, Raja GU, Mani B, Abouelhoda M, Tayeb HT (2019) Relative reduction of biological and phylogenetic diversity of the oral microbiota of diabetes and pre-diabetes patients. Microb Pathogenesis 128:215–229CrossRef Saeb AT, Al-Rubeaan KA, Aldosary K, Raja GU, Mani B, Abouelhoda M, Tayeb HT (2019) Relative reduction of biological and phylogenetic diversity of the oral microbiota of diabetes and pre-diabetes patients. Microb Pathogenesis 128:215–229CrossRef
32.
Zurück zum Zitat Nuli R, Cai J, Kadeer A, Zhang Y, Mohemaiti P (2019) Integrative analysis towards different glucose tolerance-related gut microbiota and diet. Front Endocrinol 10:295CrossRef Nuli R, Cai J, Kadeer A, Zhang Y, Mohemaiti P (2019) Integrative analysis towards different glucose tolerance-related gut microbiota and diet. Front Endocrinol 10:295CrossRef
33.
Zurück zum Zitat Larsen N, Vogensen FK, Van Den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5:e9085CrossRef Larsen N, Vogensen FK, Van Den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5:e9085CrossRef
34.
Zurück zum Zitat Schoefer L, Mohan R, Schwiertz A, Braune A, Blaut M (2003) Anaerobic degradation of flavonoids by Clostridium orbiscindens. Appl Environ Microbiol 69:5849–5854CrossRef Schoefer L, Mohan R, Schwiertz A, Braune A, Blaut M (2003) Anaerobic degradation of flavonoids by Clostridium orbiscindens. Appl Environ Microbiol 69:5849–5854CrossRef
35.
Zurück zum Zitat Lv Y, Zhao X, Guo W, Gao Y, Yang S, Li Z, Wang G (2018) The relationship between frequently used glucose-lowering agents and gut microbiota in type 2 diabetes mellitus. J Diabetes Res Lv Y, Zhao X, Guo W, Gao Y, Yang S, Li Z, Wang G (2018) The relationship between frequently used glucose-lowering agents and gut microbiota in type 2 diabetes mellitus. J Diabetes Res
36.
Zurück zum Zitat Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58:1509–1517CrossRef Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58:1509–1517CrossRef
37.
Zurück zum Zitat Shumar SA (2019) Determining the role of Nudt7 in the regulation of cellular CoA levels and metabolism. Dissertation, West Virginia University Shumar SA (2019) Determining the role of Nudt7 in the regulation of cellular CoA levels and metabolism. Dissertation, West Virginia University
38.
Zurück zum Zitat Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M (2015) Personalized nutrition by prediction of glycemic responses. Cell 163:1079–1094CrossRef Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M (2015) Personalized nutrition by prediction of glycemic responses. Cell 163:1079–1094CrossRef
Metadaten
Titel
Dairy product intake modifies gut microbiota composition among hyperinsulinemic individuals
verfasst von
Leila Khorraminezhad
Mickael Leclercq
Sarah O’Connor
Pierre Julien
S. John Weisnagel
Claudia Gagnon
Arnaud Droit
Iwona Rudkowska
Publikationsdatum
30.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 1/2021
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-020-02226-z

Weitere Artikel der Ausgabe 1/2021

European Journal of Nutrition 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.